You have 9 free searches left this month | for more free features.

Condition

Hyperlipidemia (1)

NAFLD (1)

NASH - Nonalcoholic Steatohepatitis (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Viking Therapeutics, Inc. (2)

Collaborator

Intervention

vk2809 (2)

placebo (1)

placebos (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

vk2809

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hyperlipidemia, NAFLD Trial in United States (VK2809, Placebo)

Completed

Hyperlipidemia
NAFLD

VK2809
Placebo

Chandler, Arizona
+18 more

Apr 22, 2021

NASH - Nonalcoholic Steatohepatitis Trial in Worldwide (VK2809, Placebos)

Recruiting

NASH - Nonalcoholic Steatohepatitis

VK2809
Placebos

Birmingham, Alabama
+107 more

Mar 1, 2022